Skip to content

What is the drug flunarizine used for? A Comprehensive Patient Guide

4 min read

Though not approved in the United States, flunarizine is a calcium channel blocker widely used in many parts of the world, including Europe and Asia, for the prophylactic treatment of severe and frequent migraines. Understanding what is the drug flunarizine used for is essential for patients considering this treatment option.

Quick Summary

Flunarizine is a calcium channel blocker used to prevent migraines and treat vertigo. Its effects include stabilizing neuronal activity and reducing symptoms of vestibular disorders. It is not approved in the US but is available in other countries.

Key Points

  • Primary Use: The drug flunarizine is mainly used for the prophylactic prevention of severe migraines and for treating chronic vertigo.

  • Mechanism: It functions as a selective calcium channel blocker, stabilizing neuronal activity and possessing antihistamine and dopamine blocking properties.

  • Not for Acute Attacks: Flunarizine is a preventive medication and is ineffective for treating a migraine attack once it has started.

  • Common Side Effects: Noted side effects include drowsiness, weight gain, increased appetite, and low mood.

  • Availability Varies: It is not approved by the FDA in the United States due to concerns over side effects but is licensed in many other countries.

  • Requires Medical Supervision: Due to potential side effects like depression and extrapyramidal symptoms, flunarizine should be used with careful medical guidance.

In This Article

Primary Uses of Flunarizine

Flunarizine is a medication primarily prescribed for the prophylactic treatment of migraines and the management of certain forms of vertigo. Its use is reserved for conditions that are frequent, severe, or have not responded to more common treatments. It is important to note that flunarizine is a preventive medication and is not used for treating an acute migraine attack.

Migraine Prophylaxis

For patients suffering from severe or frequent migraine attacks, flunarizine can be a valuable preventive treatment. By inhibiting the entry of calcium into nerve cells, it helps stabilize neuronal activity and increases the threshold for cortical spreading depression, a neurological phenomenon linked to migraine aura. Studies have shown that flunarizine can significantly reduce the frequency, duration, and severity of migraine attacks, though the evidence supporting it is mostly from older trials. It is particularly effective for migraines with severe neurological symptoms, such as aura.

Vertigo and Vestibular Disorders

Flunarizine is also effective in managing chronic vertigo, particularly that arising from central or peripheral vestibular disorders. Its mechanism of action helps to suppress vestibular activity and improve blood flow to the inner ear and brain. It can be effective in reducing the frequency of vertiginous attacks in conditions like vestibular migraine. Treatment for vertigo is typically continued until symptoms are controlled, often over a period of weeks to months.

How Flunarizine Works: The Mechanism of Action

Flunarizine is a selective calcium channel blocker, but its action is more complex than simply blocking calcium entry into heart and vascular muscle cells.

Key aspects of its mechanism include:

  • Calcium channel modulation: It inhibits the influx of extracellular calcium ions into neurons, which helps stabilize neuronal excitability. This is critical for preventing the excessive firing of neurons associated with migraine attacks.
  • Antihistamine activity: Flunarizine also exhibits antihistamine properties by targeting the H1 receptor, which may contribute to its effectiveness in treating certain vestibular conditions and its sedative side effects.
  • Dopamine D2 receptor antagonism: The drug's effect on dopamine receptors helps explain some of its neurological side effects, such as drowsiness and mood changes.
  • Other effects: It has neuroprotective properties and can increase the threshold for cortical spreading depression, which is a key process involved in migraine.

Important Considerations: Side Effects and Precautions

Patients taking flunarizine should be aware of its potential side effects and necessary precautions, which are primary reasons for its limited approval in some regions.

Common Side Effects

  • Drowsiness and fatigue: These are among the most frequently reported side effects and can be managed by taking the medication at night.
  • Weight gain: An increase in appetite can lead to weight gain, and patients are often advised to monitor their diet.
  • Gastrointestinal issues: Upset stomach, nausea, or heartburn may occur as the body adjusts to the medication.
  • Psychiatric symptoms: Some patients may experience a low mood or depressive symptoms, which should be reported to a doctor immediately.

Serious Side Effects

  • Extrapyramidal symptoms: In rare cases, particularly with long-term use or in elderly patients, flunarizine can cause movement disorders resembling Parkinson's disease, including tremors and rigidity.
  • Depression: Existing depression can be exacerbated, and severe depressive symptoms warrant discontinuation of the drug.

Precautions

  • Elderly patients: Older adults may be more susceptible to side effects like drowsiness and extrapyramidal symptoms and require closer monitoring and dosage adjustments.
  • Pre-existing conditions: Individuals with a history of depression or Parkinson's disease are generally advised against using flunarizine.
  • Pregnancy and breastfeeding: The safety of flunarizine in pregnant or breastfeeding women has not been established, and it is usually not recommended.

Flunarizine vs. Other Migraine Preventatives

Flunarizine's profile differs from other common migraine prophylactic drugs. Here is a comparison with propranolol, a beta-blocker, and topiramate, an anticonvulsant.

Feature Flunarizine Propranolol Topiramate
Drug Class Calcium Channel Blocker Beta-Blocker Anticonvulsant
Mechanism Modulates calcium channels, has antihistamine and anti-serotonin effects Blocks beta-adrenergic receptors Multiple actions, including modulation of GABA and glutamate
Primary Use Migraine prophylaxis, chronic vertigo Migraine prophylaxis, hypertension, anxiety Migraine prophylaxis, epilepsy
Side Effects Drowsiness, weight gain, depression, extrapyramidal symptoms Fatigue, dizziness, low blood pressure, bradycardia Paresthesia, fatigue, cognitive issues, weight loss
Availability Not available in the US; available in Europe, Asia, etc. Widely available, FDA-approved for migraine prophylaxis Widely available, FDA-approved for migraine prophylaxis
Regulatory Status (US) Not FDA-approved FDA-approved FDA-approved

Availability and Regulatory Status

Flunarizine's regulatory status varies significantly by country. It is widely licensed and available in many countries across Europe, Asia, and other parts of the world. However, it is not marketed or licensed in the United States, primarily due to concerns about its side effect profile, particularly extrapyramidal symptoms and depression. Patients in regions where it is not licensed, such as the UK, can sometimes obtain it via licensed pharmaceutical import companies under the brand name Sibelium®. Patients should consult with a healthcare professional to determine if flunarizine is a suitable option based on their location and medical history.

Conclusion

Flunarizine is a prophylactic medication primarily used to prevent severe migraines and treat chronic vertigo. Its action as a calcium channel blocker helps stabilize neuronal activity, offering a potential solution for patients who have not responded to other treatments. However, its use requires careful consideration due to potential side effects, including drowsiness, weight gain, and mood changes. Because of its side effect profile, it is not approved in all countries, notably the United States. While effective for its intended uses, it should be taken under strict medical supervision. With appropriate monitoring, flunarizine remains a valuable tool for managing complex neurological disorders for many patients worldwide. To learn more about neurological conditions, consult reputable medical resources like the National Institutes of Health.

Frequently Asked Questions

The primary use of flunarizine is for the prophylactic (preventive) treatment of severe and frequent migraines and for managing chronic vertigo and vestibular disorders.

No, flunarizine is not approved for marketing or licensed in the United States by the U.S. Food and Drug Administration (FDA), mainly due to concerns about its side effect profile.

It can take several weeks of consistent use for flunarizine to reach its maximum effect. Patients may need to take it for 6 to 8 weeks before a significant improvement is noticed.

The most common side effects are tiredness, drowsiness, weight gain, and increased appetite. Taking the medication at night can help mitigate the daytime sedative effects.

No, flunarizine is a preventive medication and is not effective for treating an acute migraine attack. It is intended to reduce the frequency and severity of future attacks.

If you miss a dose and it is close to the time of your next scheduled dose, skip the missed dose. Do not double up on doses. Return to your regular dosing schedule and inform your doctor.

Flunarizine should be used with caution or avoided by individuals with a history of depression, Parkinson's disease, or liver problems. It is also generally not recommended during pregnancy or breastfeeding.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.